Monday, July 23, 2018
Company News: Page (1) of 1 - 09/12/17 Email this story to a friend. email article Print this page (Article printing at page facebook
Integra ServiceConnect Names RaeAnn Grossman Chief Revenue Officer
(September 12, 2017)
Integra ServiceConnect  Names RaeAnn Grossman Chief Revenue Officer

Integra ServiceConnect®,a leading provider of community-based engagement services for difficult-to-reach health plan members, announced the appointment of RaeAnn Grossman as Chief Revenue Officer effective August 28, 2017. RaeAnn will be bringing with her over 20 years' senior executive experience in healthcare business strategy and product development.

Rick Hassett, MD, Chief Executive Officer of Integra notes “We couldn't be more excited to have RaeAnn join our executive team. Her impressive track record of driving significant growth in her organizations is a testament to her expertise in this sector of healthcare, and we look forward to her contributions to Integra." RaeAnn's expertise spans Medicare Advantage, Medicaid, and Commercial member engagement, risk adjustment, implementation and integration of quality and member retention initiatives. She has a wide variety of healthcare experience at organizations that include Health Plans, Medical Groups, Physician Hospital Organizations (PHOs), start-ups, Integrated Hospital Systems, and the Institute of Health Professionals Education.

“RaeAnn's experience will help us reach the next stage of growth and development, as she will work to refine our service offerings to best meet the needs of health plans, provider groups, and their members," comments Michael Yuhas, Founder and Chairman of Integra. Before joining Integra, she held executive roles with ArroHealth, Gorman Health Group, CenseoHealth and Optum. RaeAnn was also one of the founders and principal investors in a first full-service HCC management company for Medicare Advantage, where she held the position of Chief Client Services Officer. Her past roles showcase her government program expertise and her commitment to compliance.

About Integra ServiceConnect®: Integra ServiceConnect engages members through personalized face-to-face interaction, driving increased participation in risk adjustment, case management, and other clinical and quality outcome initiatives nationwide. Integra's team of highly-trained outreach specialists are consistently successful in mobilizing members that cannot or have not been engaged through standard outreach campaigns. Integra's services can be used for short-term, targeted initiatives or high-touch, long-term programs, and can be customized to meet a plan's specific needs for members in any market and line of business. Developed over time, Integra's disciplined approach includes hiring the right staff and equipping them with the training and tools necessary to achieve high levels of member engagement and satisfaction. For more information please visit

Read the full story at

Page: 1

Related Keywords:
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Sciatica Market Research Valued 18.9 Billion US$ by 2023: A Comprehensive Sciatica Market Growth by by type, by Drug Treatment and by End User
  • Medical Sensors Market to be Worth US$18.74 Billion by 2023, Says TMR
  • Vision Care Product Market To Witness Enhanced Growth Owing To Rising Occurrence Of Eye Disorders Till 2021 | Million Insights
  • Global Prosthetic Heart Valve Market Reaching at a CAGR of +12.70% by Geography, Deployment Model, Component, and Key players are Boston Scientific Cardiology, CryoLife, Inc., Abbott

  • CStone Pharmaceuticals Appoints Former Goldman Sachs Executive Richard Yeh as CFO
  • CytRx Corporation Announces Expiration of Outstanding Warrants
  • HedgePath Pharmaceuticals Granted Exclusive Option to License UCONN's Patented Chemical Analogues of Itraconazole
  • Alligator Bioscience Submits Application to Start Clinical Phase I Study in Cancer Patients with ATOR-1015, a Unique CTLA-4 and OX40 Binding Antibody
  • Yisheng Biopharma Announces Opening of New Business Divisions in Cambodia, Expanding Presence within Southeast Asia

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines